BOSTON SCIENTIFIC CORP is 2.5x more valuable than RESMED INC by market capitalization ($71.85 B vs $28.28 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BSX | RMD |
|---|---|---|
| Market cap | $71.85 B | $28.28 B |
| US-listed rank | #236 | #489 |
| Revenue (latest FY) | $20.07B | $5.15B |
| Net income (latest FY) | - | $1.40B |
| Net margin | - | 27.2% |
| P/E (trailing FY) | - | 20.2 |
| SEC filings | 1,009 | 2,518 |
BOSTON SCIENTIFIC CORP is 2.5x more valuable than RESMED INC by market capitalization ($71.85 B vs $28.28 B).
In their latest fiscal years, BOSTON SCIENTIFIC CORP reported $20.07B in revenue while RESMED INC reported $5.15B.
Full pages: BOSTON SCIENTIFIC CORP and RESMED INC, or browse the full rankings.